{"name":"BioPharmX, Inc.","slug":"biopharmx-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"BPX-01 1% Minocycline Topical Gel","genericName":"BPX-01 1% Minocycline Topical Gel","slug":"bpx-01-1-minocycline-topical-gel","indication":"Acne","status":"phase_2"},{"name":"BPX-01 2% Minocycline Topical Gel","genericName":"BPX-01 2% Minocycline Topical Gel","slug":"bpx-01-2-minocycline-topical-gel","indication":"Acne","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BPX-01, 1% Topical Gel","genericName":"BPX-01, 1% Topical Gel","slug":"bpx-01-1-topical-gel","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BPX-01, 1% Topical Gel","genericName":"BPX-01, 1% Topical Gel","slug":"bpx-01-1-topical-gel","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BPX-01 1% Minocycline Topical Gel","genericName":"BPX-01 1% Minocycline Topical Gel","slug":"bpx-01-1-minocycline-topical-gel","phase":"phase_2","mechanism":"Minocycline is a tetracycline antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit.","indications":["Acne"],"catalyst":""},{"name":"BPX-01 2% Minocycline Topical Gel","genericName":"BPX-01 2% Minocycline Topical Gel","slug":"bpx-01-2-minocycline-topical-gel","phase":"phase_2","mechanism":"Minocycline is a tetracycline antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit.","indications":["Acne"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPTWdkLXZqTVBOSkpkbFA0WHcyVzNqT0NVcTExN0ZsaDQxMnUxaHE2SDlRZUZ0UW04NWlhSkdCNDZWaEtoVzlrWnpGRi1hYUpQNzJlQnkyOUdXVlFEaDk2dlVfczVibXVHRXRaZTBERzdUMGl4MDBFVHZlNm1aTmQtck51aFdXYmlRdm5SOVFWdUJabjFwVnVpWGpWQnRldw?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Acne Treatment Market Size in the 7MM is projected to grow at a significant CAGR by 2032, estimates DelveInsight - openPR.com","headline":"Acne Treatment Market Size in the 7MM is projected to grow at a significant CAGR by 2032, estimates DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNbENZU3BnVGVQa3ZiQ0RhR3puWlpvaUJqcE9pOC0zay1yX29mNGtwNVBJQzdzSnlhaXhWelYzVVpMc2VLeFBvWkVPR2VuNUNHX1UtREp0VEZVY1RDRVIxdGlzU1ZwZlRIRVFPWWFHTS1vZEhVMGxWOVpBWnlwdFY4SThTOEowQ1llNTBwMEozR3hmYXdPZlJsNg?oc=5","date":"2026-03-11","type":"pipeline","source":"openPR.com","summary":"Acne Vulgaris Pipeline 2026: Therapies Under Investigation, - openPR.com","headline":"Acne Vulgaris Pipeline 2026: Therapies Under Investigation,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQbjdtRkl4M0Zobk5uYktGTmZpWmhsb09Ddm1sR2dVcXhMcWFKeTdxMGs2OWhHandXdEQ2a2JsVHZwMGw4NjduWnpKTG1Ddkg5QjFfTFlQWUJ6VVB0b2E1aERlOVJjMlJKMkNBN2dvaENfNlNybUtNY0JZRFgtcXE4cmYyenJuOGpKUHJOV3djZUM2NnJIRFNOclRaYWJobVhXcjB4a25aSjRRczNuM2hRcTZQTHZCVS00VnlKX2JGUEprbFdwQ2FxMWpPNUVkcjJ6d0NjRjBZblJWVGxCSkIyWlNtOTJucFRtWHE3Q3dnSndMUXAtY2Jfc2lmOVRwcGM?oc=5","date":"2024-01-22","type":"pipeline","source":"Lowenstein Sandler LLP","summary":"Lowenstein Represents Timber Pharmaceuticals as Special Corporate Counsel in Chapter 11 and Asset Sale to Leo Pharma A/S - Lowenstein Sandler LLP","headline":"Lowenstein Represents Timber Pharmaceuticals as Special Corporate Counsel in Chapter 11 and Asset Sale to Leo Pharma A/S","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxOTzd0VHZtSWZSWldNOTU5eGNfM0JDczRScHVuZElzUFBVakpHcUdKaUV2MkZOQmhFMVgyQjNRd3d4cFdTUDFEQl9ZLXo2ZmpwN1pJSS0wcFJqRHpZVWR5N281QlZFWndraU1uSVVpWjNqUG9RVnBJamVxN1NVREhNM0MzYkdlM0RCeEp3TzdsUE9mdy1XZ1U3RmxIeVNMSExQUjhWOUdTX3lkRm1KN0NqN09PVjhWZ3FuSWFwbTdnWjhGeHlPTXIzczUxTnJ2V2x5RnRjZmZzcFJfa3FGcFRCOHRkQUZiR1V1OHBYSVJ3MzNVb3lYSWhPVUNlUE1yWmpRMmJrZ0NlTF9sazdDSmpOWlhFTzFjMnl6SjdpcjBzbVpDdDZyeE5DZUVXaS1tQnZncmsyWFNMVDRJRjctclBFaU9qa1duNFFDSkxpQTY4Z28?oc=5","date":"2024-01-15","type":"pipeline","source":"PR Newswire","summary":"Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key Companies - Pfizer, ModernaTX, Tarsus Pharmaceuticals, Valneva, Cortene - PR Newswire","headline":"Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key Companies ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPSkVyLXJveUlyMmRPWXlTVlh4blBHaW1GenU2OXBrQ0lualhaLUR1YlBfN1dMMGVJNHg1dlBMWjhKOXg1WmsyZGFTNk50R1pvakRlWVdISHkyekpqLXdlc0NjNjB6eUxMTmFtb1Y0RHFJSHVIeDFvS3c0OU9QSmh4TlNwSUZiQQ?oc=5","date":"2022-06-06","type":"pipeline","source":"Dermatology Times","summary":"Rosacea Recap: Comparing Treatment Options - Dermatology Times","headline":"Rosacea Recap: Comparing Treatment Options","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNNDRFcHk1X1VSSnRlUDhWZld3ektqalNGbF93Y0tOdlVUQ1VNZ2V3YVp4NTZkaDY4aTlWUHRxRTVHZy1TTFhRUXpMNkp6Z2JuYjRPX0FtbW10c1JkZEE2Q0Nud09hZVZ0THhqVDc1SldUSkpYRU9sZ3Fna0N4eDhGV3V0dXZDU2R1R3QxVjlkUFhPNnVacXlwOUFiRy03OFFjbFY2QTdGb2NzekE5WGZKRURaSXlteDhuZTFsbFRTRHJwcUE1SENEa2ZoZk1DVW80MHB5bmc4S2RJMW9jV0d6cThsN0pPQmM?oc=5","date":"2020-05-18","type":"deal","source":"Lowenstein Sandler LLP","summary":"Lowenstein Represents Timber Pharmaceuticals in Closing of Merger With BioPharmX Corporation (Skolnick) - Lowenstein Sandler LLP","headline":"Lowenstein Represents Timber Pharmaceuticals in Closing of Merger With BioPharmX Corporation (Skolnick)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOU3RfWXJGLUpvMEZBQXl5N3dZSTJXSUp4TWZfVnlGOU1TN2FjeVA3RUw3U0tvYmc2cF9LODc1WmZULW5CM0NXa1BuZm1uYkFHZDFsWmZDdjYtOG41MEpCa0xVd0F6S2Z0Um5rUW1aVHg3MlktTk5yQy0wbjRnTDVSN1NEdUMwdzBvTUl0alZFaGV6MEU1TThvdkpvd1A1UlNGb3dBa1pn?oc=5","date":"2020-05-18","type":"deal","source":"PR Newswire","summary":"Timber Pharmaceuticals Announces Merger Closing - PR Newswire","headline":"Timber Pharmaceuticals Announces Merger Closing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNUmdRS3otblhDbFNLODBlOE42RXBJZnlXTTl2UTBfTjMwNWdUV2ZlVTlYVXBmLWFWaVduWnYwMWFvMlpRc2hTcUFMYjg0YkVxcjFsTmNueUwzSUdlYzlNeDdTeEpXUU51bEVMY1V4R0dmc0t3eHZRS0wzZ3VERUVwdGlGdzJ5UzJ1dWhvUVdBVnNLS2dzUkptRzRaZkVJYl9CUFpPV09TUlJvMlVVSk9zQVpwTnplcWJ2bXdyWEJSR0YwU3hDLXh0LWlIQXNwdGZmUHBOamViQ1M?oc=5","date":"2020-05-13","type":"regulatory","source":"PR Newswire","summary":"BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting - PR Newswire","headline":"BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPRXJpRnJzQmxXbjhWTElIY0FlWWJNb0JQOGZYa1k5eWt0RnpHdmZFUHRrVXQ3UHZ3TXpFVkxGdHlGMXRVUk5HczN4SE9MSlRPUFV4S0lPTmRGQjlUbkRTVWJKbXpYakl2UnZBYW9xNFNyZ096eG1QNWZWNUE5OWxwRk1sbTVSaGtvUlowTTdMRkVpdXhMVmF4WE5XSnVhcDBXU3lJSGhFMjY3NFd6YVpkUllTS2tieUVHdVV5SElVUHpOaWhLNGxQTQ?oc=5","date":"2020-01-28","type":"deal","source":"PR Newswire","summary":"BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement - PR Newswire","headline":"BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFBfLThWOWdFN0tWMy12VFZEZHVnNldPM0JtVjJvZ2MzQ2poZVhMcWJfRHZSV1lUb1IxdjRJNExsZUxualR3ckpKSTFJYmVjb1l3Q3FsS0ZfUWJQdlFRT1RfNHR3?oc=5","date":"2017-11-13","type":"pipeline","source":"MarketBeat","summary":"Biopharmx (BPMX) Stock Price, News & Analysis - MarketBeat","headline":"Biopharmx (BPMX) Stock Price, News & Analysis","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}